Codiak BioSciences' GAAP loss for 3 months of 2022 was $8.028 million, down 22.1% from $10.308 million in the previous year. Revenue decreased 3.7% to $12.704 million from $13.191 million a year earlier.
Codiak BioSciences' GAAP loss for 3 months of 2022 was $8.028 million, down 22.1% from $10.308 million in the previous year. Revenue decreased 3.7% to $12.704 million from $13.191 million a year earlier. 
ir.codiakbio.com
English (US) 